Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0001367644-23-000071

President and CEO acquired 57,693 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kramer Robert President and CEO 2023-03-02 Grant or award +19,231 255,289 D: show line 1 in the form
Kramer Robert President and CEO 2023-03-02 Grant or award +38,462 293,751 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Kramer Robert President and CEO 2023-03-02 Grant or award · Employee Stock Options (Right to Buy) +38,462 258,182 D: show line 3 in the form
Loading xslF345X03/wf-form4_167814941740129.xml…